Crossmark

Evaluation of the Keeogo exoskeleton for assisting ambulatory activities in people with multiple sclerosis: an open-label, randomized, cross-over trial

Crossref DOI link: https://doi.org/10.1186/s12984-018-0468-6

Published Online: 2018-12-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McGibbon, Chris A. http://orcid.org/0000-0001-7849-7895
Sexton, Andrew

Jayaraman, Arun

Deems-Dluhy, Susan

Gryfe, Pearl

Novak, Alison

Dutta, Tilak

Fabara, Eric

Adans-Dester, Catherine

Bonato, Paolo
Funding

Funding for this research was provided by:

BTemia Inc (Contract)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 18 April 2018

Accepted: 27 November 2018

First Online: 12 December 2018

Ethics approval and consent to participate

: All sites received ethics approval from their respective IRB/REB and all subjects provided signed informed consent prior to participation. Site approvals were as follows: 1) University of New Brunswick (REB# 2015–127: University of New Brunswick Research Ethics Board, Fredericton, NB), 2) Shirley Ryan AbilityLab/ Rehabilitation Institute of Chicago (STU00201422: Northwestern University, Institutional Review Board, Chicago, IL), 3) Spaulding Rehabilitation Hospital (2015P001485/SRH: Spaulding Rehabilitation Network Research Institute, Institutional Review Board, Boston, MA), 4) Toronto Rehabilitation Institute (REB# 15–9445-D: University Health Network, Research Ethics Board, Toronto, ON) and the 5) Assistive Technology Clinic (REB#16–40: Baycrest Research Ethics Board, Toronto, ON).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below